I'm looking for experts with experience in men’s health/treating ED and treating hair loss/prescribing hair loss meds to answer the following questions: 1. From a mechanistic standpoint, how might finasteride’s inhibition of 5-alpha-reductase contribute to sexual side effects such as erectile dysfunction or decreased libido? 2. Based on the current body of research, how robust is the evidence linking finasteride use to erectile dysfunction? How has this understanding evolved since the early clinical trials and post-marketing reports? 3. The concept of “post-finasteride syndrome” remains controversial. What’s your perspective on the quality and consistency of evidence supporting persistent sexual dysfunction after discontinuation of the drug? 4. For patients who experience sexual side effects while taking finasteride, what does the clinical evidence indicate regarding reversibility? Are there known strategies or treatments that can aid recovery? 5. In your clinical or research experience, how common are sexual side effects among men taking finasteride, and are there identifiable risk factors that make some patients more susceptible? 6. How do other hair loss medications compare in terms of sexual side effects? Are there alternatives that appear safer from a sexual health standpoint? 7. Beyond sexual health, what other side effects or systemic considerations should clinicians and patients be aware of when prescribing or taking finasteride or other hair loss drugs? Thank you in advance!

Finasteride can cause sexual side effects in a small group of men because it blocks 5 alpha reductase, which lowers dihydrotestosterone or DHT. Since DHT supports libido and erectile function, cutting it down can sometimes lower sex drive or make erections weaker. It doesn't happen often, but some people just react more to hormone changes than others. The research on finasteride and erectile function is mixed. Early studies showed under 2 percent of men had problems and most got better after stopping. Later studies found that a few had longer lasting issues, so it seems like recovery depends on how quickly someone's hormones rebalance. Post finasteride syndrome is still controversial. Some men report symptoms after quitting, but studies aren't consistent. It's tricky because both physical and mental factors may play a part. So while it looks rare, it's real enough to keep paying attention to. Most people who notice side effects do recover after they stop taking it. Hormones usually settle back to normal. Some switch to topical versions or low dose minoxidil to lower overall effects and still help hair regrowth. Older men or those on other hormone meds tend to notice more side effects, while younger guys often bounce back faster. Dutasteride lowers DHT even more than finasteride, so side effects might be a bit more common. Topical options are usually easier on the system. Some people also say they notice mood changes or mental fog. Those usually fade after the drug clears. Finasteride is good for slowing hair loss, but since everyone's body reacts differently, it's smart to weigh how it helps your hair against how it makes you feel overall. Josiah Roche Fractional CMO, JRR Marketing https://josiahroche.co/ https://www.linkedin.com/in/josiahroche

You're asking how finasteride's 5-alpha-reductase inhibition could drive sexual side effects, how strong the ED link is, and what to make of "post-finasteride syndrome," reversibility, risk factors, alternatives, and other safety issues. Mechanistically, blocking 5-AR lowers DHT and alters downstream sex-hormone and neurosteroid signaling (e.g., allopregnanolone), which plausibly affects libido, erectile function, and mood. Early trials suggested small absolute increases vs. placebo, but over time pharmacovigilance and observational data have strengthened signals for ED and broader sexual AEs, while regulators have added neuropsychiatric warnings (the EMA formally listed suicidal thoughts in 1-mg finasteride in May 2025). NCBI +2 PMC +2 From my vantage point advising men's-health brands on content accuracy, I've watched teams revise risk disclosures after FDA/EMA communications and route patients to clinicians when side effects emerge—especially switching some to minoxidil, which tends to have fewer systemic sexual effects compared with 5-AR inhibitors. The evidence for persistent dysfunction after stopping ("post-finasteride syndrome") is mixed: case series and signal analyses describe ongoing sexual and neuropsychiatric symptoms, but causality and prevalence remain debated; many patients improve after discontinuation, while others report lingering issues. Practical, clinician-led steps include stopping or lowering dose, considering non-5-ARI options (topical or low-dose oral minoxidil), and treating ED directly (e.g., PDE5 inhibitors), while monitoring mood and fertility parameters; dutasteride appears similar or potentially higher-risk on sexual AEs. Beyond sexual health, counsel on mood changes/suicidality, gynecomastia, semen changes/fertility, and handling precautions (exposure risk in pregnancy), and avoid compounded/topical finasteride products that lack approval and have drawn recent FDA safety alerts.